StockData
Standard BioTools Inc. logo

Standard BioTools Inc. (LAB) stock

LABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/3085% below fair value
$0.71+0.06 (+8.60%)

Close on Nov 13, 2026Market cap $277.71MP/E 3.2Yield –

Standard BioTools total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2012 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2012Dec 31, 2012$0-100.0%
FY2011Dec 31, 2011$10.14M-31.0%
FY2010Dec 31, 2010$14.70M–

More Standard BioTools figures

See a number that looks wrong?